Individualized Treatment May Improve Outcomes in Gastroesophageal Cancer
Oncology Nursing News,
Offering patients with metastatic gastroesophageal tumors a more personalized and adaptable treatment approach using monoclonal…
Offering patients with metastatic gastroesophageal tumors a more personalized and adaptable treatment approach using monoclonal…
A 1-year overall survival (OS) rate of 66% (95% CI, 54%-76%) was reported in the 68 patients who comprised the intent-to-treat…
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in…
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in…